Respiratory outcome of spinal muscular atrophy type 1 patients treated with nusinersen
{{output}}
Background: Respiratory failure is the leading cause of mortality in spinal muscular atrophy type 1 (SMA1) children. The current study aims to evaluate the effect of nusinersen treatment on respiratory outcome of the patients wit... ...
